Skip to content

Clinical trials

Phase 3 Carcinoma, Renal Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 3 Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20101
20121
20161
20172
20181
20212
20222
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Recruiting4
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
GlaxoSmithKline2
Novartis Pharmaceuticals2
AstraZeneca1
Bayer1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Peking University Cancer Hospital & Institute1
Pfizer1
RenJi Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell19
Neoplasm Metastasis3
Kidney Neoplasms2
Carcinoma1
Colonic Neoplasms1
Emergence Delirium1
Neoplasms1
Postoperative Cognitive Complications1
Prostatic Neoplasms1
Rectal Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.